Skip to main content
TipRanks
Go Ultimate75% OFF

EM Systems Co (EMO) AI Stock Analysis

1 Followers
DE:EMO

EM Systems Co

(Frankfurt:EMO)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Conservative Balance SheetVery low leverage and a sizable, stable equity base provide financial resilience and flexibility. This conservative funding structure can help EM Systems continue investing in healthcare IT solutions, absorb operating variability, and avoid excessive interest burdens over the next several quarters.
Negative Factors
Cash Flow VolatilityThe sharp 2025 reduction in operating and free cash flow shows that reported profitability does not consistently translate into cash. Persistent volatility could constrain internally funded investment, reduce capital allocation flexibility, and make operating performance harder to forecast over the next several quarters.

EM Systems Co (EMO) vs. iShares MSCI Germany ETF (EWG)

-50%-40%-30%-20%-10%0%10%20%DE:EMO-28.03%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 212.70M
Dividend Yield
4.64%
Average Volume (3M)
―
Price to Earnings (P/E)
26.1
Beta (1Y)
0.31
Revenue Growth
-23.62%
EPS Growth
-54.69%
Country
Germany
Employees
858
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

EM Systems Co Business Overview & Revenue Model

Company Description

EM Systems Co., Ltd. is a Japanese company that specializes in providing a comprehensive suite of IT solutions designed for pharmacies, medical clinics, and social welfare/care facilities. Its product portfolio for pharmacies encompasses systems for...

EM Systems Co Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:EMO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:2413JP:241379OutperformJPY 1.25T26.7211.33%1.19%9.48%2.08%
JP:4480JP:448063NeutralJPY 82.54B43.3812.35%―21.01%10.15%
JP:4483JP:448361NeutralJPY 260.15B34.32―0.47%20.50%19.27%
JP:4438JP:443854NeutralJPY 2.34B-4.32――14.84%30.67%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%DE:EMOJP:2413JP:4480JP:4438JP:4483Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:EMO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:EMOEM Systems Co 3.06-1.21-28.37%
JP:2413M3 1844.50-855.94-31.70%
JP:4480Medley, Inc.2608.00331.0014.54%
JP:4438Welby Inc.270.00-87.00-24.37%
JP:4483JMDC Inc.3850.00-508.80-11.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.